Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

NCT00045318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: exatecan mesylate

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]